⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EDIT News
Editas Medicine, Inc. Common Stock
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
globenewswire.com
EDIT
Editas Medicine to Participate in Upcoming Investor Conferences
globenewswire.com
EDIT
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL
Cell and Gene Therapy in Numbers: $1.2B in Zolgensma Sales, $1.5B Yescarta Revenue, 46 FDA-Approved Therapies and $2B Strategic Deals
globenewswire.com
NVS
GILD
BMY
REGN
CRSP
NTLA
EDIT
BBIO
AZN
SGMO
Leading Chinese Innovative Medical Device Maker Insight Lifetech Has Successfully Listed on STAR Market USA - English APAC - Traditional Chinese USA - English
prnewswire.com
AAPL
TSLA
XOM
MSFT
GOOGL
AMZN
NVDA
META
BRK.A
JPM
V
JNJ
PG
MA
HD
UNH
DIS
BAC
PFE
MRK
TMO
ABT
MDT
BMY
AMGN
GILD
AZN
LLY
BIIB
REGN
VRTX
ALGN
ISRG
TDOC
EXAS
ZLAB
SCHR
APT
BILI
HSAI
UBOT
TIGR
INSM
YXT
CCEL
IMUX
INCY
CRSP
EDIT
NTLA
SRPT
EXEL
LULU
CROX
NKE
CPRI
PVH
RL
URBN
M
KSS
TJX
BBY
ROST
DLTR
WMT
TGT
COST
SBUX
MCD
CMG
YUM
QSR
CBRL
TXRH
NDSN
TTWO
EA
NTDOY
SONY
MSGS
AMC
IMAX
RCL
CCL
NCLH
AAL
DAL
UAL
LUV
ALK
JBLU
SKX
ADBE
CRM
INTC
AMD
QCOM
AMAT
MU
NXPI
SNPS
CDNS
ASML
PAYX
ADP
NOW
CSCO
ORCL
IBM
HPQ
DELL
ACN
INFY
SAP
ERIC
NOK
STM
UL
PEP
KO
Quantum Secure Communication Market to Reach US$ 1,861.78 Million by 2035 Driven by Capital Inflows, Government Initiatives, and Telecom Network Adoption Says Astute Analytica
globenewswire.com
GOOG
JPM
VZ
T
TM
NTES
CHTR
ARQQ
KT
SKM
TSLA
MSFT
AMZN
NVDA
IBM
QCOM
INTC
CSCO
ORCL
CRM
ACN
ADP
FIS
PYPL
COIN
MU
ADI
NXPI
ON
QTRX
AEHR
MCHP
SWKS
QRVO
AVGO
MRVL
AMD
IONQ
RIG
CRIS
EDIT
NTLA
ALNY
BIIB
GILD
REGN
AMGN
BMY
PFE
MRK
ABBV
LLY
SNY
AZN
NVS
XOM
CVX
SHEL
BABA
JD
PDD
BIDU
IQ
VIPS
NIO
LI
XPEV
RIVN
LCID
F
GM
STLA
HMC
SONY
HPQ
DELL
HPE
Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine
globenewswire.com
NTLA
EDIT
CRSP
Cell and Gene Therapy Market Poised for US$ 183.1 Billion Growth by 2035 | Astute Analytica
globenewswire.com
NTLA
EDIT
Gene Therapy Investment Trends Strategic Intelligence Report 2026: Market to Reach $42.26 Billion by 2033 | Astute Analytica
globenewswire.com
EDIT
NTLA
PFE
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL